Celgene names new chairman of board of directors
7 February 2018 -

United States-based Celgene has named Mark Alles as its new chairman of the board of directors, it was reported yesterday.

Alles will also remain as CEO in addition to his new position. He succeeds Bob Hugin, executive chairman, who is retiring from the firm after 19 years of service and who stepped down from the board of directors effective 5 February.

Alles has been with the company since 2004, holding roles including chief operational officer and executive vice president, global head of haematology and oncology.